Details werden geladen...
Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference | The Manila Times
Presentations feature mechanistic data on ACR-2316, a potential first-in-class, clinical WEE1/PKMYT1 inhibitor, rationally designed with AP3 for potent single agent activity and superior therapeutic index
Ähnliche Seiten
Remix Therapeutics to Present at AACR Drug Discovery and Development Conference | The Manila Times
https://www.manilatimes.net/2026/07/16/tmt-newswire/globenewswire/remix-therapeuticsto-present-at-aacr-drug-discovery-and-development-conference/2385755
DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration | The Manila Times
https://www.manilatimes.net/2026/06/04/tmt-newswire/globenewswire/daltontx-launches-its-drug-discovery-platform-dalton-and-announces-sygnature-discovery-collaboration/2358506Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development | The Manila Times
https://www.manilatimes.net/2026/07/15/tmt-newswire/pr-newswire/insilico-medicine-and-bora-pharmaceuticals-announce-strategic-alliance-for-ai-driven-drug-discovery-and-development/2384638QCI to Showcase Unified Resort Intelligence Platform at Raving's Casino Marketing & Technology Conference and Host & Player Development Conference | The Manila Times
https://www.manilatimes.net/2026/07/02/tmt-newswire/globenewswire/qci-to-showcase-unified-resort-intelligence-platform-at-ravings-casino-marketing-technology-conference-and-host-player-development-conference/2377107Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations | The Manila Times
https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/crinetics-paradigm-shifting-portfolio-and-pipeline-on-display-at-endo-2026-with-six-presentations/2356535